LONDON, October 2 /PRNewswire/ -- Commenting on the figures out today from the Department of the Environment, which showed that between 2005 and 2006, the number of households classified as fuel poor jumped by one million to 3.5 million, Tony Woodley, joint general secretary of Unite said:

"When the Government's own report acknowledges that millions more households have been pushed into fuel poverty as a direct result of increases in consumer energy prices, then it is time to stop talking to these companies about lagging the lofts and start making them do their duty by those in desperate need.

LONDON, October 2 /PRNewswire/ -- Emailvision, the European market and technology leader in on-demand software for e-mail marketing automation, today announced that Nick Gold has joined the group as Head of Sales for the UK.

NEW YORK, October 2 /PRNewswire/ --

- To Support Growing Demand for E-Mail Marketing Software & Services

Emailvision, a global leader in on-demand software for email marketing announced today that it has opened a New York office to expand its global reach and provide service and support to a growing list of International clients. Heading the NY office is Olivier Piscart who joined Emailvision in 2003.

"This office will give Emailvision a strategic presence in the New York Metropolitan area and allow us to better serve the email marketing requirements of our clients in the US and in Europe," says Nick Heys, founder & CEO of Emailvision.

PARIS, October 2 /PRNewswire/ -- Valeo, always at the forefront of the latest developments in vehicle access systems, will unveil its smart key at the Paris Motor Show.

The smart key provides a genuine interface between driver and car, allowing people to send information to their vehicle over a considerable distance (several hundred meters). The key's mini screen displays information such as whether the doors are locked and the alarm is activated, tire pressure and fuel tank level. The key can be used to preprogram the seat position or radio station, to pre-ventilate the cabin, and to exchange navigation destinations downloaded from a computer. Information can also be exchanged between keys.

PARIS, October 2 /PRNewswire/ -- Pharmaleads has obtained from the French Medicine Agency (AFSSAPS) the authorization to perform a single ascending dose Phase I study with PL37, its lead compound for oral treatment of neuropathic pain.

Neuropathic pain is a major chronic pain condition, with an estimated prevalence in the world's population of up to 6%, according to the most recent surveys, with many causes such as shingles, herpes, diabetes, antiviral or antitumor chemotherapy surgery, or low back disorders. Neuropathic pain does not respond well to usual painkillers. Worldwide market for neuropathic pain is estimated to reach 5 billion USD by 2010.

REHOVOT, Israel and JERSEY CITY, New Jersey, October 2 /PRNewswire/ --

- The Study Will Compare the Results of Rosetta Genomics' microRNA-based Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous non Small Cell Lung Cancer, With Current Diagnostic Methods

- A Test Based on the miRview(TM) Technology First Approved for Clinical use Through Columbia University's High Complexity Molecular Pathology Lab Earlier This Year

- Rosetta Genomics is Expecting to Launch miRview(TM) Squamous Later This Year Through its Recently Acquired CLIA lab in Philadelphia

REHOVOT, Israel and JERSEY CITY, New Jersey, October 2 /PRNewswire/ --